drugset / Trial / NCT05199155

Use of a Nerve Regeneration Conduit (NerVFIX®) in the Treatment of Nerve Section of the Wrist

NCT05199155 ↗

Phase 2 Terminated 12 enrolled TBF Genie Tissulaire
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this open, multicenter trial is to assess the impact of a nerve regeneration conduit made of allogeneic artery or vein from umbilical cord lining on the regeneration of wrist nerve.

Timeline

Start
2020-12-08
Primary completion
2024-08-13
Completion
2024-08-13

Outcome

Outcome not reported

Stopped (Enrollment): “Low accrual rate”

Drugs

EvaluationDrugModalityDoseRoute
Subject NerVFIX Other / unclassified — —